OTTAWA – Health Canada is updating the label for the Oxford-AstraZeneca and COVISHIELD COVID-19 vaccines to add capillary leak syndrome as a potential side-effect.
The agency is also including a warning for patients with a history of the ailment to not get those vaccines.
Capillary leak syndrome is a very rare, serious condition that causes fluid leakage from small blood vessels (capillaries)s struggles in COVID-19 fight, hope o, which can result in the swelling of the arms and legs, sudden weight gain, low blood pressureThe government views as essential travel while B.C. considers using roadblocks to discourage people from leaving their health authority region., thickening of the blood and low levels of the albumin blood proteinThe area.
Health Canada and the Public Health Agency of Canada have been monitoring the condition since it was raised as a potential safety concern by the European Medicines Agency in Aprilre a little bit more i.